Exenatide 2 MG

DRUG2 trials

Sponsors

Consano Clinical Research, LLC, Peking Union Medical College Hospital

Conditions

Diabetes Mellitus, Type 2Polycystic Ovary Syndrome

Phase 4

Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.

CompletedNCT03970044

Consano Clinical Research, LLCDiabetes Mellitus, Type 2

Start: 2019-07-02End: 2021-06-01Updated: 2021-08-30

Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients

Peking Union Medical College HospitalPolycystic Ovary Syndrome

Start: 2019-07-20End: 2020-12-31Target: 80Updated: 2019-07-23

Related Papers

Combined metformin and exenatide versus only metformin treatments in polycystic ovary syndrome with abdominal obesity and network pharmacology of gene expression: evidence from a randomized clinical trial

Therapeutic Advances in Endocrinology and Metabolism2025-08-01

Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome

Chinese Medical Journal2021-11-0346 citations